Sonoma Pharmaceuticals, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Sonoma Pharmaceuticals, Inc. on February 7, 2018. The report serves to announce the company's financial results for the fiscal quarter ended December 31, 2017. The full details of these results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing does not explicitly list material changes versus the prior comparable period within the body of the 8-K. Investors must refer to the attached press release for comparative financial data.
Guidance, Outlook, and Risks
The report includes a standard disclaimer regarding forward-looking statements. Management notes that these statements involve risks, uncertainties, and assumptions that could cause actual results to differ materially from expectations. Specific risks are referenced as being discussed in the company's Annual Report on Form 10-K. The company does not undertake an obligation to update these forward-looking statements except as required by law.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 2017 revenue and net income figures.
- Examine the attached presentation (Exhibit 99.2) for management's strategic outlook.
- Consult the most recent Form 10-K for a detailed list of risk factors.
- Verify the company's cash position and liquidity status in the full press release.